Table: Noile-Immune Biotech - 9-MTH parent results

Noile-Immune Biotech

13/11/2025 06:34

Nov 13 (Reuters)- 
             Noile-Immune Biotech Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Sep 30, 2025        Sep 30, 2024      Dec 31, 2025  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             5 mln               5 mln             5 mln     
                 (-8.2 pct)          (-98.3 pct)       (-34.1 pct)  
  Operating     loss 608 mln        loss 892 mln      loss 812 mln  
  Recurring     loss 602 mln        loss 785 mln      loss 806 mln  
  Net           loss 605 mln        loss 787 mln      loss 809 mln  
  EPS          loss 13.97 yen      loss 18.18 yen    loss 18.70 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Noile-Immune Biotech Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T